Despite the similar pattern of association between risk of breast cancer and effect modification with ER, in our study there was only weak correlation between Ki67 and EZH2, and no significant change in the magnitude of the association between EZH2 and breast cancer risk when including Ki67 expression as a covariate in the model. Here, ESR1 is linked to breast cancer.